JW (Cayman) Therapeutics Balance Sheet Health
Financial Health criteria checks 4/6
JW (Cayman) Therapeutics has a total shareholder equity of CN¥1.7B and total debt of CN¥262.5M, which brings its debt-to-equity ratio to 15.6%. Its total assets and total liabilities are CN¥2.1B and CN¥462.3M respectively.
Key information
15.6%
Debt to equity ratio
CN¥262.50m
Debt
Interest coverage ratio | n/a |
Cash | CN¥1.01b |
Equity | CN¥1.68b |
Total liabilities | CN¥462.26m |
Total assets | CN¥2.15b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 2126's short term assets (CN¥1.1B) exceed its short term liabilities (CN¥264.5M).
Long Term Liabilities: 2126's short term assets (CN¥1.1B) exceed its long term liabilities (CN¥197.8M).
Debt to Equity History and Analysis
Debt Level: 2126 has more cash than its total debt.
Reducing Debt: 2126 had negative shareholder equity 5 years ago, but is now positive and has therefore improved.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Insufficient data to determine if 2126 has enough cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if 2126 has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.